Accretive Health, Inc.  

(Public, NYSE:AH)   Watch this stock  
Find more results for AH
13.58
+3.57 (35.66%)
Jul 31 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 12.98 - 14.19
52 week 7.75 - 32.82
Open 13.10
Vol / Avg. 0.00/793,068.00
Mkt cap 1.35B
P/E 45.25
Div/yield     -
EPS 0.30
Shares 99.35M
Beta     -
Inst. own 58%
Aug 8, 2012
Q2 2012 Accretive Health, Inc. Earnings Conference Call - 8:30AM EDT - Add to calendar
May 10, 2012
Accretive Health, Inc. at Robert W Baird's Growth Stock Conference - Webcast
May 9, 2012
Q1 2012 Accretive Health, Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin 0.59% 3.53%
Operating margin 0.92% 5.82%
EBITD margin - 6.82%
Return on average assets 1.55% 9.31%
Return on average equity 2.43% 15.32%
Employees 2,721 -
Carbon Disclosure Rating - -

Address

Suite 2700, 401 North Michigan Avenue
CHICAGO, IL 60611
United States - Map
+1-313-3247820 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Accretive Health, Inc. (Accretive Health) is a provider of services to the healthcare providers. The Company�s three offerings are revenue cycle management; quality and total cost of care, and physician advisory services. Its integrated revenue cycle management service offering helps the United States healthcare providers to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation and collections. Accretive Health�s customers are multi-hospital systems, including faith-based or community healthcare systems, academic medical centers and independent clinics, and the physician practice groups affiliated with those systems.

Officers and directors

J. Michael Cline Independent Chairman of the Board
Age: 52
Bio & Compensation - Reuters
Mary A. Tolan President, Chief Executive Officer, Director
Age: 51
Bio & Compensation - Reuters
Etienne H. Deffarges Vice Chairman of the Management Board
Age: 54
Bio & Compensation - Reuters
John T. Staton Chief Financial Officer, Treasurer
Age: 51
Bio & Compensation - Reuters
Walter H. Ettinger Jr. Senior Vice President - Quality and Total Cost of Care
Age: 48
Bio & Compensation - Reuters
Richard E. Gillette Senior Vice President
Age: 49
Bio & Compensation - Reuters
Gregory N. Kazarian Senior Vice President
Age: 49
Bio & Compensation - Reuters
Edgar M. Bronfman Jr. Independent Director
Age: 56
Bio & Compensation - Reuters
Steven N. Kaplan Independent Director
Age: 52
Bio & Compensation - Reuters
Stanley N. Logan Independent Director
Age: 57
Bio & Compensation - Reuters